InfuSystem Holdings, Inc. (INFU) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
INFU Revenue Growth
Revenue Breakdown (FY 2024)
INFU's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
INFU Revenue Analysis (2014–2025)
As of May 7, 2026, InfuSystem Holdings, Inc. (INFU) generated trailing twelve-month (TTM) revenue of $143.4 million, reflecting solid growth of +7.0% year-over-year. The most recent quarter (Q4 2025) recorded $36.2 million in revenue, down 0.7% sequentially.
Looking at the longer-term picture, INFU's 5-year compound annual growth rate (CAGR) stands at +8.1%, indicating steady revenue expansion. The company achieved its highest annual revenue of $143.4 million in 2025, representing a new all-time high.
Revenue diversification analysis shows INFU's business is primarily driven by Patient Services (57%), and Device Solutions (43%). With over half of revenue concentrated in Patient Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including BRT (+1.5% YoY), HCSG (+7.1% YoY), and OPRX (+18.8% YoY), INFU has underperformed the peer group in terms of revenue growth. Compare INFU vs BRT →
INFU Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| INFUCurrent | $143M | +7.0% | +8.1% | 8.3% | |
 BRT | $97M | +1.5% | +28.1% | 11.4% | |
 HCSG | $1.8B | +7.1% | +0.9% | 2.6% | |
 OPRX | $109M | +18.8% | +20.4% | 10.7% | |
 ACLX | $22M | -79.4% | - | -1135.6% | |
 OMCL | $1.2B | +7.9% | +5.8% | 0.4% |
INFU Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $143.4M | +6.4% | $80.3M | 56.0% | $11.9M | 8.3% |
| 2024 | $134.9M | +7.2% | $70.4M | 52.2% | $6.9M | 5.1% |
| 2023 | $125.8M | +14.4% | $63.1M | 50.2% | $4.1M | 3.3% |
| 2022 | $109.9M | +7.4% | $60.6M | 55.1% | $1.7M | 1.5% |
| 2021 | $102.4M | +5.1% | $58.5M | 57.2% | $2.8M | 2.8% |
| 2020 | $97.4M | +20.1% | $58.8M | 60.3% | $8.8M | 9.1% |
| 2019 | $81.1M | +20.8% | $46.9M | 57.8% | $3.5M | 4.3% |
| 2018 | $67.1M | -5.5% | $39.0M | 58.1% | $415K | 0.6% |
| 2017 | $71.1M | +0.8% | $43.4M | 61.0% | $-3,812,000 | -5.4% |
| 2016 | $70.5M | -2.3% | $44.7M | 63.5% | $974K | 1.4% |
See INFU's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INFU Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare INFU vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonINFU — Frequently Asked Questions
Quick answers to the most common questions about buying INFU stock.
Is INFU's revenue growth accelerating or slowing?
INFU maintains +7.0% revenue growth, in line with its 5-year CAGR of +8.1%. TTM revenue stands at $143M. Growth rate remains consistent with historical average.
What is INFU's long-term revenue growth rate?
InfuSystem Holdings, Inc.'s 5-year revenue CAGR of +8.1% reflects the sustained expansion pattern. Current YoY growth of +7.0% is near this long-term average.
How is INFU's revenue distributed by segment?
INFU reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.